Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units

BACKGROUND: Clinical metagenomics (CMg) has the potential to be translated from a research tool into routine service to improve antimicrobial treatment and infection control decisions. The SARS-CoV-2 pandemic provides added impetus to realise these benefits, given the increased risk of secondary inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Charalampous, Themoula, Alcolea-Medina, Adela, Snell, Luke B., Williams, Tom G. S., Batra, Rahul, Alder, Christopher, Telatin, Andrea, Camporota, Luigi, Meadows, Christopher I. S., Wyncoll, Duncan, Barrett, Nicholas A., Hemsley, Carolyn J., Bryan, Lisa, Newsholme, William, Boyd, Sara E., Green, Anna, Mahadeva, Ula, Patel, Amita, Cliff, Penelope R., Page, Andrew J., O’Grady, Justin, Edgeworth, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594956/
https://www.ncbi.nlm.nih.gov/pubmed/34784976
http://dx.doi.org/10.1186/s13073-021-00991-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594956/
https://www.ncbi.nlm.nih.gov/pubmed/34784976
http://dx.doi.org/10.1186/s13073-021-00991-y

Ejemplares similares